Physio-Control's Lifepak 12 Stimulates Wall Street - Stock Up 31% In April
This article was originally published in The Gray Sheet
Executive Summary
Physio-Control's release of higher than anticipated first-quarter results April 20, driven by strong initial demand for the firm's recently introduced Lifepak 12 external defibrillator/monitor, translated into a stock price increase of 31.4% for the month. The issue closed April at 23 after gaining 5-1/2 points.